多囊卵巢综合征的胰岛素抵抗研究进展

　　11 La Marca A，Morgante G，Palumbo M，et al.Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating normone in women with polycystic ovary syndrome[J].Fertil Steril，2002，78(6)：1234-1239

　　12 Huber BMM，Carey DGP，Norman RJ，et al.Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome：Role of insulin sensitivity and luteinizing hormone[J].J Clin Endocrinol Metab，1999，84(4)：1470-1474

　　13 Ciotta L，De Leo V，Farina M，et al.Endiocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia[J].Gynecol Obstet Invest，2001，51(1)：44-50

　　14 Moghetti P，Castello R，Negri C，et al.Metformin effects on clinical features，endocrine and metabolic profiles，and insulin sensitivity in polycystic ovary syndrome：a randomized，double-blind，placebo-controlled 6-month trial，followed by open，long-term clinical evaluation[J].J Clin Endocrinol Metab，2000，85(1)：139-146

　　15 Glueck CJ，Wang P，Goldenberg N，et al.Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin[J].Hum Reprod，2002，17(11)：2858-2864

　　16 Glueck CJ,Wang P，Koboyashi S，et al.Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome[J].Fertil Steril，2002，77(3)：520-525

　　17 周海燕.罗格列酮治疗多囊卵巢综合征25例临床分析[J].中国妇幼保健，2007，22(1)：33-35

　　18 Fulghesu AM，Mario-Ciampelli M，Giuseppe-Muzj G，et al.N-acetyl-cysteine treatment improves insuline sensitivity in women with polycystic ovary syndrome[J].Fertil Steril，2002，77(6)：1128-1135

　　19 Nestler JE，Jakubowicz DJ，Reamer P，et al.Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome[J].N Engl J Med，1999，340(17)：1314-1320

　　20 Ciotta L，Calogero A

上一页  [1] [2] [3] [4] [5] 下一页